Alternatives to DDxHub

ClinCapture's mission is to create software that saves lives. ClinCapture's technology reduces the cost of clinical trials. It streamlines data capture and protects patient privacy. Clincapture is a platform that facilitates the evaluation and development drugs, biologics and devices that have the potential to treat a wide variety of medical conditions or diseases.

Sunwave Health (Sunwave) drives healthy results for behavioral health and Substance Use Disorder treatment providers through a fully integrated solution that supports the entire treatment journey. Sunwave supports traditional capabilities provided by CRM, EMR, RCM, HR, and billing solutions. But we go father to ensure results. As the only 4th generation, fully integrated treatment journey platform, we drive results using complete analytics, on-demand intelligence, and intuitive reporting. There is a reason we are the highest rated in customer satisfaction.

The Montreal Cognitive Assessment (MoCA) is a concise, 30-item evaluation designed for healthcare professionals to identify cognitive deficits at an early stage, facilitating quicker diagnoses and enhanced patient management. This tool enables both healthcare providers and researchers to recognize cognitive challenges associated with various conditions, including Alzheimer's disease, Parkinson's disease, and several others such as frontotemporal dementia and brain tumors. MoCA is frequently utilized by a diverse range of practitioners, including nurses, primary care doctors, specialists, occupational therapists, and psychologists, among others. It efficiently evaluates critical cognitive functions such as short-term memory, visuospatial skills, executive functioning, attention, and language abilities, as well as orientation to time and place. The versatility of MoCA makes it an essential component of cognitive health assessments across various settings.

Mahalo Health is an integrated digital health platform aimed at expediting the creation of patient-focused digital health solutions and clinical trials. By providing a variety of prebuilt modules, Mahalo facilitates the swift launch of customizable white-label applications that cater to particular therapeutic fields. The platform boasts comprehensive data capabilities, featuring a predictive health engine for forecasting diseases and diagnoses, a behavior modification engine to encourage beneficial patient behaviors, and a notification system that ensures timely communication through push notifications, SMS, or emails. Committed to maintaining high security and compliance standards, Mahalo follows regulations such as HIPAA, GCP, ISO27001, and GDPR. Its extensive range of services encompasses multiple therapeutic areas, including diabetes, cognitive health, cardiovascular issues, musculoskeletal conditions, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Additionally, Mahalo Health empowers healthcare providers with tools to enhance patient engagement and outcomes through its innovative digital solutions.

This Screening Tool is designed to assist you in assessing potential COVID-19 symptoms based on the criteria set by the Centers for Disease Control. The recommendations you receive will rely heavily on the accuracy of the details you share, as well as the up-to-date guidelines for identifying COVID-19 symptoms. After you complete the survey, the tool will generate a response that should be communicated to your employer, following their specific instructions. It’s important to note that this tool is not a replacement for professional medical advice, diagnosis, or treatment related to any health conditions, including COVID-19. For any serious symptoms or emergencies, always reach out to a qualified medical professional for assistance. Additionally, staying informed about health guidelines can further enhance your understanding of COVID-19 and its implications.

BrainSightAI is an innovative health technology firm that harnesses the power of artificial intelligence and machine learning to transform the field of brain mapping through AI-driven connectomics, allowing for the creation of customized brain maps. The VoxelBox product line employs these AI techniques to produce individualized brain maps tailored to each patient's needs. These advanced tools are specifically designed to facilitate pre-surgical preparation and enhance patient outcomes for those suffering from brain tumors and various neurological issues. Collaborating with top hospitals across the country, BrainSightAI is engaged in clinical trials that explore a range of brain-related ailments such as Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Committed to pushing the boundaries of brain science, our overarching goal is to improve quality of life by offering state-of-the-art resources that deepen our understanding of the human brain and its complexities. By continually refining our technology and methodologies, we aspire to make significant contributions to the medical community and the lives of patients.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

Accelerating the speed, precision, and affordability of cancer diagnoses is crucial, especially considering that one in three individuals will face this disease in their lifetime. Unfortunately, the current diagnostic process is often hindered by slow and costly methods, primarily due to the lack of advanced automated tools that support healthcare professionals. Qritive addresses this challenge by offering an AI-driven solution designed to assist physicians in analyzing both microscopy images and textual patient data efficiently. This innovation not only enhances the effectiveness of hospitals in diagnosing cancer but also contributes to significant cost savings. Additionally, Pantheon serves as a CE-marked, vendor-agnostic digital pathology platform that facilitates the complete digitization of pathology lab workflows and telepathology. It also supports comprehensive report generation and offers a robust platform for AI-driven analysis of whole-slide images in pathology. This technology is particularly adept at distinguishing between a variety of benign conditions and malignant diseases within breast tissue, which is vital for timely and accurate treatment. In doing so, it plays a pivotal role in transforming the landscape of cancer diagnostics.

Medical AI represents a groundbreaking technological advancement that effectively tackles chronic illnesses. This innovative solution is distinguished by its capabilities to forecast outcomes, recommend optimal subsequent actions, and deliver information in a user-friendly manner. DeLorean Medical AI enhances human decision-making, paving the way for a future where both machines and humans collaboratively achieve superior results. Our technology not only enhances health outcomes but is also the first AI system to receive biological validation through independent clinical evaluations. By improving the classification of patient demographics, assessing risk factors, and forecasting transitions in disease states, Medical AI plays a crucial role in the early detection and diagnosis of various health conditions. Additionally, it contributes to cost reductions within healthcare systems. With over ten clients already utilizing our solution, it has proven effective in generating savings and reducing costs through real-time analytics that identify at-risk populations and provide next-best-action suggestions grounded in statistical evidence. Furthermore, as the healthcare landscape continues to evolve, the integration of such advanced technologies will become increasingly vital in ensuring better patient care and resource management.

The integration of artificial intelligence is set to revolutionize the field of healthcare diagnosis. By leveraging AI and predictive analytics, we can achieve early detection of diseases and enhance diagnostic accuracy. Our cloud-based AI platform aims to make healthcare more affordable and accessible for everyone. Endimension Technology, a healthcare AI startup fostered at IIT Bombay, specializes in developing advanced algorithms that identify abnormalities and diseases from medical imaging. Our team comprises experts in machine learning, software engineering, and medical professionals from esteemed institutions. We are dedicated to creating AI-driven healthcare solutions that will significantly minimize the incidence of patient misdiagnosis. Furthermore, our technology is designed to alleviate the workload of radiologists while simultaneously improving the speed at which patients receive their results, ultimately leading to better healthcare outcomes. By harnessing the power of AI, we envision a future where diagnostic processes are more efficient and reliable.

Behavioral health constitutes a crucial yet frequently neglected component of overall wellness. The impact of mental and substance use disorders affects an astonishing 970 million individuals globally, contributing to an economic burden exceeding US $1 trillion each year. In spite of this escalating crisis, advancements in treatment and understanding have not kept pace with other medical fields. Alarmingly, less than half of those suffering from major depression, which is the most prevalent mental health disorder, achieve remission with existing therapies. Increased awareness has sparked a greater demand for services in a system that remains ill-equipped to address the extensive complexities of this need. There exists a significant evidence gap that hinders progress in research and innovation, largely due to the inherent challenges within behavioral health, such as intricate disease causes, a shortage of measurable biomarkers, and fragmented institutional approaches. Even after many years of dedicated research, we remain largely in the dark about how to effectively treat most behavioral health conditions, indicating a critical need for renewed focus and resources in this field. Ultimately, bridging this gap is essential for improving the lives of millions affected by these disorders.

Enhance your ability to manage risks and deliver superior care to your community through the disease prediction models offered in CARE™. We provide a comprehensive perspective of medical claims data at a national scale, which can be tailored to meet the specific needs of our clients at a granular level. Our sophisticated models sift through billions of medical claims to pinpoint risk indicators for early disease development or the necessity for surgical interventions. Armed with this vital information, healthcare providers can initiate diagnoses and treatments earlier, which has the potential to save lives. While our prediction models are trained on extensive national data, they can also be applied to your own EHR, population health platform, or member claims database for a more personalized approach. Additionally, our physician matching feature aids in aligning patients with the most suitable providers, thereby enhancing their care journey towards optimal treatment outcomes. By utilizing clinically significant data, our advanced disease prediction models identify individuals who are at risk of developing a condition, empowering you to proactively engage with them and commence treatment before the situation escalates. This proactive engagement not only improves patient outcomes but also enhances the overall efficiency of healthcare delivery.

The microbiome plays a significant role in various diseases and health issues. Discover how Kaleido is pioneering a unique method to transform the potential of the microbiome into effective patient solutions. Comprising over 30 trillion microbes, the human microbiome includes a diverse array of organisms such as bacteria, viruses, archaea, and fungi that inhabit both the exterior and interior of the human body. In recent years, there has been a remarkable surge in research focusing on the microbiome's influence on human health, linking it to conditions such as cardiovascular disease, cancer, diabetes, Parkinson’s disease, and allergies. This intricate microbial community has been likened to a "newly discovered organ," highlighting its significance. Just as many human organs command substantial investments for therapies that modify physiology, the microbiome represents a largely unexplored territory in the realm of healthcare. Addressing this frontier could unlock new therapeutic avenues and enhance overall health outcomes.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

We combine clinical and experimental data through machine learning techniques to explore human disease biology and promote the development of precision medicine. Our innovative Contingent AI™ technology comprehends the intricate relationships present in the data, yielding advanced insights. To combat data bias, we refine our machine learning models based on decisions made during the pre-processing and feature engineering phases. We utilize zebrafish, cellular, and various phenotypic animal models to test and confirm in silico predictions through in vivo experiments, along with genetic modifications conducted both in vitro and in vivo to enhance translation. By employing active learning and computer vision on validated models that focus on cardiac, central nervous system, and rare disorders, we swiftly integrate new data into our machine learning frameworks, allowing for continuous improvement and adaptation in our methodologies. This iterative process not only enhances the accuracy of our predictions but also enables us to stay at the forefront of research in precision medicine.

Every template consists of specific tasks that, when performed correctly, contribute to achieving a diagnosis or resolving a case. The workflows are designed to proceed in a sequential manner. The PatientCare™ software enables users to establish follow-up procedure templates for each condition included in the test panel. Each template is composed of distinct tasks that, if executed correctly, will facilitate a diagnosis or the resolution of a case. These workflows progress in a linear fashion. Patient cases can be located using search folders and are managed through various functions such as overseeing open and closed action items, accessing information related to tests and specimen results, tracking notes, assigning them to specific cases, and auditing actions associated with the cases to ensure accuracy and completeness. Efficient management of these processes is crucial for optimal patient care.

Dynamic Health serves as a comprehensive, evidence-driven resource aimed at empowering nurses and allied health practitioners to enhance their skills, quickly find answers to clinical queries, and cultivate a commitment to evidence-based practices and critical analysis that ultimately leads to better patient care. The EBSCO team has expanded the already extensive content of Dynamic Health, now incorporating detailed discussions on evidence-based topics related to diseases and conditions, including their signs, symptoms, diagnostic tests, and care interventions, all tailored to meet the decision-making requirements of healthcare professionals. Furthermore, Dynamic Health simplifies the process of obtaining continuing education units (CEUs) through its integrated learning system, allowing users to earn credits while addressing clinical inquiries. This resource also provides a comprehensive overview of various diseases and conditions, along with valuable insights on abnormalities that may signify underlying medical issues, thereby enhancing the interprofessional team's ability to deliver quality care. By bridging the gap between knowledge and practice, Dynamic Health equips healthcare providers with the necessary tools to support informed decision-making and improve overall patient outcomes.

Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.

Utilizing a blend of advanced data mining techniques and natural language processing, CAT can efficiently pull text and specific portions from any healthcare document, identifying key components like medication names, medical procedures, diagnoses, and various disorders. With the information gathered on procedures and diagnoses, CAT is also able to formulate a Diagnosis Related Group (DRG) or an Emergency Medical Service (EMS) level. Additionally, CAT assesses the document against various PQRS measures to ensure compliance. This technology extracts text from medical documents and swiftly transforms it into a format suitable for billing, achieving a remarkable level of accuracy. By streamlining this process, CAT enhances operational efficiencies and generates cost savings for hospitals, medical practices, and other healthcare providers that need coding services. The time spent on billing and coding sees a significant reduction, while the precision of claim submissions is greatly enhanced through this automated approach, which not only speeds up the claim processing time but also improves the overall revenue cycle for healthcare organizations. As a result, healthcare facilities experience a smoother financial operation and can focus more on patient care.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

We are at the forefront of precision medicine, alleviating the strain on healthcare systems through our innovative automated analysis, diagnosis, and treatment solutions that cater to healthcare providers and patients globally. Congenica emerged from groundbreaking research conducted at the Wellcome Sanger Institute and the UK's National Health Service. Our offerings integrate cutting-edge technology, top-tier automation, and artificial intelligence, allowing our distinct platform to be utilized across various human diseases where genomic information plays a crucial role in revealing actionable insights. As a digital health company, we specialize in software and solutions designed for the large-scale analysis and interpretation of genomic data. Our fully automated system, enhanced with robust APIs and machine learning capabilities, aims to lighten the load on specialist staff, improve case processing efficiency, speed up decision-making, and simplify reporting. Our platform is certified, accurate, and secure, empowering clinical decisions with the utmost confidence in the resulting clinical outcomes, and we continuously strive to innovate and expand our capabilities to meet the evolving needs of the healthcare landscape.

TheraScribe streamlines the process of developing treatment plans, progress notes, and homework assignments, saving you valuable time and effort. By simply clicking and choosing from a selection of customizable, prewritten statements crafted by professionals, you can effectively articulate the client's symptoms, treatment goals, short-term objectives, clinician's therapeutic interventions, and diagnoses, resulting in a comprehensive, evidence-based treatment plan. You can also further click to access prewritten statements for progress notes and tailored homework that addresses the primary concerns presented by the client. Additionally, the user-friendly Appointment Scheduler allows you to organize your client's sessions, with the added convenience of exporting to Outlook for better management. TheraScribe also offers the option to set up Treatment Plan Review Reminders at customizable intervals, ensuring you never miss an important check-in. Furthermore, the Clinical Pathway feature provides the ability to create a reusable template for treatment plans, complete with predefined problems, definitions, goals, objectives, interventions, and diagnoses, making it easier for clinicians to maintain consistency and efficiency in their practice. This comprehensive approach not only enhances workflow but also improves the quality of care provided to clients.

Legion Health is a modern telepsychiatry service that connects patients with board-certified providers who diagnose and treat the most common mental health conditions, including ADHD, depression, anxiety, bipolar disorder, PTSD, and sleep issues. The company accepts major insurance plans, making high-quality psychiatric care financially accessible for millions of people. New patients can complete a brief intake, browse provider profiles, and schedule a virtual appointment that fits their schedule—often as soon as the next day. During each online visit, clinicians offer thoughtful assessments, medication plans, and ongoing follow-up care tailored to the patient’s needs. Legion Health emphasizes warm, judgement-free support, ensuring every session feels safe and understanding. Prescriptions are managed seamlessly, with medication coordination handled quickly and professionally. Patients also benefit from flexible follow-up options, evening availability, and a team that remains closely engaged throughout treatment. With its blend of convenience, expertise, and empathetic care, Legion Health helps individuals take meaningful steps toward a healthier, more stable life.

Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.

Suvoda is a worldwide leader in clinical trial technology, focusing on intricate, life-preserving studies in fields like oncology, central nervous system conditions, and rare diseases. Established in 2013, the company provides a comprehensive platform featuring Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all aimed at streamlining essential patient interactions. Their innovative software design guarantees a fluid user experience, enabling accurate randomization, efficient drug supply management, and immediate data collection. With a strong commitment to improving patient understanding and alleviating the demands on trial sites, Suvoda's offerings are designed to evolve alongside the increasing complexities of clinical trials. Based near Philadelphia, with additional offices across Europe and Asia, Suvoda has successfully supported over 1,500 trials in more than 85 countries, showcasing their global reach and expertise in the field. Their dedication to innovation and excellence positions them as a vital partner in the advancement of clinical research.

Inactivity is a significant contributor to various lifestyle diseases, such as diabetes and stress-related conditions. These health issues often arise from a combination of poor dietary choices and insufficient physical activity, which can lead to obesity. Moreover, engaging in unhealthy habits like smoking increases the risk of developing serious illnesses, including cancer and cardiovascular diseases, as well as complications such as blood clots linked to elevated cholesterol levels. Stress, another prevalent lifestyle disease, can impact individuals regardless of their employment status, manifesting as a feeling of inadequacy in meeting personal or societal expectations. Furthermore, loneliness, which is relatively common in Nordic countries, can exacerbate feelings of isolation and may lead to depression, highlighting the importance of social connections for mental well-being. It is crucial to address these interconnected issues to promote a healthier lifestyle and overall quality of life.

VSClinical facilitates the clinical analysis of genetic variants in accordance with ACMG and AMP guidelines. Its structured workflow supports adherence to the American College of Medical Genetics (ACMG) standards, which are essential for identifying and categorizing pathogenic variants related to inherited disease risk, cancer susceptibility, and rare disease diagnosis. The combined ACMG/AMP guidelines for variant interpretation establish a framework for scoring variants and categorizing them into one of five classification levels. Implementing these guidelines necessitates a thorough examination of annotations, genomic contexts, and pre-existing clinical insights for each variant. VSClinical streamlines this process by offering a customized workflow that evaluates each relevant criterion and supplies comprehensive bioinformatics, literature references, and clinical knowledgebase evidence to aid in the scoring and interpretation of variants. This innovative approach is designed to enhance the efficiency of variant scientists as they navigate the complexities of variant processing and analysis. Overall, VSClinical stands out as a vital tool for accelerating the understanding and classification of genetic variants in clinical settings.

Founded in 2016, Infervision stands at the forefront of AI-driven medical technology, dedicated to enhancing multidisciplinary healthcare services and operations through innovative artificial intelligence solutions. Their advanced AI offerings are designed to assist healthcare professionals across a spectrum of tasks, including disease screening, diagnosis, intervention, treatment, patient management, and medical research. Among their array of solutions, InferRead CT Lung specializes in detecting lung nodules from chest CT scans, while InferRead DR Chest focuses on identifying chest abnormalities via X-ray imaging. Moreover, InferRead CT Coronary is tailored for recognizing coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is adept at triaging hemorrhages from brain CT scans. The company also provides InferRead CT Bone for spotting chest fractures in CT images and InferRead CT Pneumonia for diagnosing and managing pneumonia cases. Beyond these, their offerings extend to InferOperate, which facilitates 3D reconstruction for thoracic, liver, and urological surgical procedures, and InferCare, a tool designed for effective patient management and image follow-up. Additionally, InferScholar acts as an AI-enhanced resource for medical research, further solidifying Infervision's commitment to transforming healthcare through AI technology. This comprehensive suite of solutions positions Infervision as a pivotal player in the evolution of medical practices.

An AI-driven solution for public health screening utilizing X-Ray and CT scans focuses on detecting chest abnormalities such as Tuberculosis and infections similar to COVID-19. This advanced technology enhances X-ray imaging for identifying patterns associated with infectious diseases like TB and COVID-19, allowing for immediate prescreening and triage. We have refined the entire workflow to ensure that imaging assessment, diagnosis, and reporting are carried out without any complications. A smart notification system alleviates the pressure involved in the reporting process. The solution boasts three primary features: classifying, localizing, and quantifying lesions. By harnessing the power of Artificial Intelligence, we are committed to delivering prompt and efficient teleradiology services to the worldwide imaging community, ultimately improving patient outcomes and streamlining healthcare delivery.

IntelliSpace Portal 9.0 is an innovative visualization platform encompassing over 70 clinical applications, providing a cohesive solution that enhances speed and efficiency while boosting diagnostic confidence, particularly in the analysis and monitoring of complex cases. As the global population ages, the prevalence of neurodegenerative diseases continues to escalate, necessitating long-term monitoring for patients with neurological disorders, which can often exhibit subtle brain changes that are difficult to identify. To address these challenges, IntelliSpace Portal 9.0 introduces several new and improved neuro applications, including NeuroQuant®¹, LoBi, and CT Brain Perfusion, all designed for swift, objective, and consistent image assessment. Additionally, with a growing focus on pulmonary health, this platform equips you with a comprehensive suite of tools to seamlessly manage pulmonary disease from initial detection through to ongoing follow-up, ultimately aiming to improve patient outcomes. This integration of neuro and pulmonary features positions IntelliSpace Portal 9.0 as a vital resource in modern medical imaging and diagnostics.

Grounded in established medical science and transparent systems biology, DARA enhances clinical decision-making and intervention strategies. Collaborating with healthcare providers and relevant stakeholders, we deliver digital solutions that revolutionize health screening and the management of chronic diseases. Our approach facilitates the digital evolution of care delivery through the automation of clinical workflows and the use of predictive analytics, all aligned with leading clinical guidelines and best practices. By offering actionable health insights through tailored predictions of disease risk and potential adverse events, we empower physicians to better connect with their patients. Additionally, we support pharmaceutical development by uncovering pharmacodynamics within intricate biological systems and discovering innovative therapeutic options. Utilizing predictive analytics on comprehensive patient data allows for personalized precision medicine, particularly in managing cardiometabolic diseases to avert severe patient outcomes. With our tools, healthcare can become more proactive and responsive, ultimately leading to improved patient care and health outcomes.

An AI-driven solution utilizing X-Ray and CT scans is designed for public health screening, focusing on identifying chest pathologies such as Tuberculosis and COVID-19-related infections. This innovative system, known as Genki, integrates "AI+Expert in the loop" to deliver a comprehensive imaging workflow, where artificial intelligence enhances the capabilities of imaging specialists, resulting in quicker report generation and increased productivity. Utilizing cutting-edge technology, Genki effectively augments X-ray imaging for the analysis of infectious diseases like TB and COVID-19, offering rapid prescreening and triage capabilities. We have meticulously refined the entire workflow to facilitate a seamless process for imaging assessment, diagnosis, and reporting, while a smart notification system alleviates the stress often associated with reporting tasks. Key features of Genki include the ability to classify, localize, and quantify lesions effectively. The solution emphasizes point-of-care diagnostics, which is essential for addressing the gaps in disease elimination, and can be integrated into mobile X-ray units and CT scanners, ensuring immediate triage and prescreening when needed. This approach not only enhances efficiency but also significantly contributes to improving public health outcomes.

Engage with a medical-focused generative AI that not only elucidates its responses but also cites relevant references, refreshes its medical knowledge on a daily basis, and allows users to personalize and select knowledge bases. This AI comes equipped with a pre-loaded database and has been trained using over 2,300 reference datasets put together by experts in the medical field, encompassing a wide array of terminologies, medical research, clinical trials, patents, population health insights, costs, as well as public and regulatory information. It indexes numerous sources of medical research and data, ensuring a comprehensive understanding of the available information. The system is designed to receive daily updates on the latest medical findings, clinical trial results, and evolving terminologies, making it capable of processing vast quantities of documents, potentially reaching into the millions or billions. Moreover, the cluster can be scaled according to specific requirements. As a type of conversational AI, a medical chatbot employs natural language processing (NLP) technologies to communicate with users, delivering valuable medical information, guidance, or assistance. These chatbots serve various functions, including addressing general inquiries regarding diseases, health concerns, and available treatment options, thus enhancing the accessibility of medical knowledge for users everywhere.

Ampersand Health implemented an 8-week support initiative aimed at individuals with IBD who suffer from chronic pain and fatigue. Following the completion of the programme, a significant enhancement in the group average scores from the ACT survey was observed (n=21, p<0.0001). These findings indicate that participants were able to foster acceptance and psychological flexibility, gain a deeper understanding of their chronic symptoms, and feel a sense of connection, realizing they can lead a fulfilling life despite the ongoing challenges of pain and fatigue. While the study anticipated no change in the physical levels of chronic pain and fatigue, self-reported outcomes revealed a shift in how symptoms were perceived following participation in the programme. Measurements of symptoms and disease activity, assessed through a validated Patient Reported Outcome Measure, remained stable throughout the duration of the trial. This highlights the importance of psychological support alongside physical health management for chronic illness sufferers.

AarogyaAI is a software-as-a-service platform that utilizes artificial intelligence to identify drug-resistant tuberculosis (DR-TB) within hours. Our goal is to provide rapid and precise diagnoses of DR-TB, ensuring that patients receive the most effective drug combinations for their treatment without delay. Tuberculosis is responsible for more fatalities annually than AIDS, largely because the 19 available anti-TB medications do not work for all patients, leading to uncertainty among doctors regarding the appropriate treatment options. Consequently, even though tuberculosis is treatable, a delayed diagnosis of drug-resistant forms can result in patients remaining on ineffective medications for as long as seven years. By diagnosing drug-resistant tuberculosis swiftly, we enable prompt and appropriate treatment prescriptions. Patients upload a DNA sequence to our platform, and our advanced machine learning algorithm processes this data to generate a detailed report on drug susceptibility status, allowing healthcare providers to make informed decisions about treatment. This innovative approach not only enhances patient outcomes but also aims to reduce the overall burden of tuberculosis on healthcare systems.

The Cambridge Neuropsychological Test Automated Battery (CANTAB), which was initially created at the University of Cambridge, provides highly accurate and objective assessments of cognitive abilities that are linked to neural networks. With the capability to detect variations in neuropsychological performance, CANTAB encompasses a wide array of tests that evaluate working memory, learning, and executive function, as well as visual, verbal, and episodic memory; attention, information processing, and reaction time; social and emotional recognition, decision-making, and response control. These cognitive evaluations serve as crucial instruments for unraveling the complexities of specific brain functions associated with various disorders and conditions, offering valuable insights into their underlying causes, facilitating the early detection of symptoms, and assessing the impact of interventions aimed at enhancing brain health. By utilizing the CANTAB, researchers and clinicians can better understand cognitive impairments, leading to more effective strategies for treatment and support.

A secure and top-tier prescription writing system ensures a reliable approach to managing patient medications. It conducts a thorough comparative analysis of a patient's medical history while checking for potential drug interactions and brand compatibility. This facility offers automatic safety checks for medications and allows users to search for appropriate drugs and brands effortlessly. Records from every patient visit are maintained in a chronological format, streamlining the process. Generating a new prescription can be accomplished in under two minutes, enhancing efficiency. The system scans a patient’s previous medical and familial history to provide valuable insights and recommendations. It also assesses drug safety concerning specific conditions, such as G6PD deficiency, porphyria, hypertension, and COPD, thus simplifying the workflow for both healthcare providers and patients. With comprehensive prescribing information for approximately 70,000 brands from Indian, British, and American pharmaceutical databases, users have access to a wealth of resources. Additionally, it includes complete monographs for nearly 3,000 generic drugs sourced from reputable references like the PDR of the U.S.A., Martindale’s pharmacology, and the British National Formulary, encompassing complete diagnostic details, differential diagnoses, and treatment protocols for a variety of conditions. This innovative system not only improves the quality of patient care but also enhances the overall management of healthcare practices.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

ONEai Health provides a state-of-the-art clinical surveillance platform that consolidates biometric information from smart wearables and medical devices to keep track of patients, utilize AI for trend analysis, and send alerts if conditions start to deteriorate. Its innovative BIO-EYE system employs predictive analytics tailored to specific diseases, allowing for the early identification of health declines in individuals suffering from chronic illnesses like congestive heart failure, chronic obstructive pulmonary disease, diabetes, hypertension, and sepsis. This facilitates timely interventions and helps to minimize hospital admissions. The platform integrates real-time vital signs, including heart rate, SpO₂ levels, heart rate variability, stress levels, sleep patterns, and physical activity through tools like Apple HealthKit. Additionally, it offers easy access via a mobile application for patients and ensures secure data sharing with healthcare teams. By consistently monitoring the health progress of patients, ONEai Health empowers clinicians to take earlier action, enhance patient outcomes, reduce healthcare costs, and extend monitoring capabilities into recovery environments, long-term care facilities, and patients' homes, ultimately promoting overall health and well-being.

Share your health information, pose relevant inquiries, and receive exceptional answers from our virtual health assistant. Select a physician tailored to your specific requirements from top medical institutions across the US and Europe. Obtain a written medical second opinion or engage in a video consultation, all within the comfort of your home. Any information shared during your use of our services is safeguarded through advanced encryption and security measures that align with HIPAA and GDPR regulations. While the Docus AI health assistant is engineered to operate as an AI doctor and deliver precise and pertinent information based on its programming, it is crucial to acknowledge that it cannot assure total accuracy. Always seek the advice of a healthcare professional for a conclusive diagnosis and treatment strategy. Although the Docus AI health assistant functions as an AI doctor, it is vital to remember that it is not a substitute for the skills and knowledge of a licensed medical practitioner. This ensures that you have both options and support available for your healthcare needs.

The expenses, intricacies, and lengthy timelines tied to traditional methods of evidence generation hinder the agile nature of research and the broader incorporation of genuine patient insights within treatment development and commercial processes. Our HyperStream serves as the largest real-time stream of patient experience data globally, documenting the genuine digital narratives of diseases as expressed by real patients on various online platforms. Pharos acts as a web-based tool for evidence generation and a research framework that leverages its combined data streaming and AI functionalities to effectively gather online patient experience data, allowing teams to swiftly uncover vital evidence when necessary. Thus far, the Pharos Suite has proven effective in generating valuable evidence and patient insights across a variety of therapeutic areas and medical conditions, demonstrating its versatility and impact on research practices. This innovative approach not only enhances the speed of evidence gathering but also enriches the understanding of patient experiences in real-time.

During the Covid-19 pandemic, advancements in medical imaging were urgently implemented to enhance both diagnosis and patient care pathways. This involved a variety of diagnostic studies, the strengthening of teleradiology services, the enforcement of social distancing measures, and efforts to predict the disease's progression. Furthermore, solutions were developed to assist vulnerable populations, including the elderly and individuals with disabilities. A modular information system was introduced for healthcare facilities to streamline their medical imaging processes. Evolucare Imaging offers a web-based, collaborative RIS-PACS solution aimed at maximizing the efficiency of medical imaging departments. With a strong focus on healthcare IT, Evolucare strives to connect various aspects of healthcare, providing effective and economically viable tools for improved patient care. The company’s capabilities stem from the diverse expertise of its technical and business teams, along with a robust support system that ensures quick responses to client needs. In this way, Evolucare continues to play a pivotal role in transforming the landscape of medical imaging.

Gather an extensive profile for each Key Opinion Leader (KOL) and relevant stakeholders, including their contact information and a general overview of their activities. Additionally, compile the social media presence of individuals engaged in the targeted community to tailor specific content towards them. Create a detailed map of interactions to provide a comprehensive view of the community of interest. Bluenod delivers essential insights to the healthcare sector by categorizing therapeutic areas based on various diseases or medical specialties. Specifically, the pharmaceutical sector seeks our expertise to guide both pre-launch and post-launch initiatives. Furthermore, media companies can enhance their content promotion strategies by connecting with influential figures. Political entities can identify key players within their influence networks to facilitate engagement. Whether for informing about the phases surrounding a product launch or for connecting with influential clients, Bluenod's reports are instrumental in supporting prominent organizations within their respective communities, ultimately fostering more effective communication and collaboration. This approach ensures that all stakeholders are informed and engaged in a relevant and impactful manner.

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

When individuals are dealing with a common cold or managing long-term illnesses such as diabetes or heart disease, they frequently have inquiries and concerns that require attention, as well as guidance to help ensure they comprehend and stick to their treatment plans. Health Dialog presents a collection of tailored population health solutions designed to tackle these challenges, empowering your members to enhance their overall health while simultaneously decreasing costs. Our team of healthcare professionals provides personalized health coaching through targeted outreach to assist members in better managing chronic conditions, including asthma, diabetes, and heart disease. We pinpoint members who may be at risk of not following their treatment plans, identify the most effective ways to engage them, and offer education to promote consistent medication adherence. Additionally, your members can benefit from round-the-clock access to a live registered nurse who is available to deliver clinical advice, refer them to necessary services, teach vital skills, and provide pertinent educational resources to support their health journey. This comprehensive approach not only enhances member engagement but also fosters a more informed and health-conscious community.